Skip to main content
Livermore
Livermore
ZHEN

Glen Eagle Advisors, LLC

SEC CIK
0002029317
Latest filing
Aug 14, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Glen Eagle Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
4,500
Value
$408.3K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by Glen Eagle Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,500$408.3K0.1%−292−6.1%ReducedHolders
Q1 20264,792$492.0K0.1%−202−4.0%ReducedHolders
Q4 20254,994$625.7K0.1%+14+0.3%AddedHolders
Q3 20254,980$667.0K0.1%+110+2.3%AddedHolders
Q2 20254,870$662.4K0.1%−626−11.4%ReducedHolders
Q1 20255,496$729.0K0.1%+10+0.2%AddedHolders
Q4 20245,486$620.5K0.1%+2,111+62.5%AddedHolders
Q3 20243,375$384.8K0.1%+3+0.1%AddedHolders
Q2 20243,372$350.3K0.1%+117+3.6%AddedHolders
Q1 20243,255$370.0K0.1%+245+8.1%AddedHolders
Q4 20233,010$331.3K0.1%−6−0.2%ReducedHolders
Q3 20233,016$292.1K0.1%−96−3.1%ReducedHolders
Q2 20233,112$339.2K0.1%−91−2.8%ReducedHolders
Q1 20233,203$324.3K0.1%+87+2.8%AddedHolders
Q4 20223,116$342.1K0.1%+16+0.5%AddedHolders
Q3 20223,100$300.0K0.1%+91+3.0%AddedHolders
Q2 20223,009$326.9K0.1%+154+5.4%AddedHolders
Q1 20222,855$337.9K0.1%00.0%UnchangedHolders
Q4 20212,855$401.8K0.1%−454−13.7%ReducedHolders
Q3 20213,309$390.9K0.1%+16+0.5%AddedHolders
Q2 20213,293$381.8K0.1%00.0%UnchangedHolders
Q1 20213,293$394.6K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.